Kengreal (cangrelor) - Chiesi
ticagrelor - Generic mfg.
aspirin - Generic mfg.
Use of cangrelor in neuroendovascular interventions: real-world evidence from a single-center cohort. (PubMed, Neuroradiology) - Aug 18, 2026 - "Although this study has an exploratory nature, cangrelor provided effective and safe peri-procedural platelet inhibition, ensuring high rates of stent patency and low rates of bleeding in both AIS and aneurysm-related populations requiring emergency stenting. Given the clinical heterogeneity between these cohorts, these preliminary observations should be interpreted separately and considered hypothesis-generating. Larger prospective studies are needed to confirm these findings." 
HEOR • Journal • Real-world evidence • Cardiovascular • Hematological Disorders • Hypertension • Ischemic stroke • Vascular Neurology
http://www.ncbi.nlm.nih.gov/pubmed/42606718
 
Alessandro Onori; Alessandro Tanzilli; Angelo Pompucci; Antonio Ciacciarelli; Cesare Ambrogi; Ermanno Notarianni; Flavio Andresciani; Giuseppe Pelle; Graziano Taddei; Lorenzo Tenore; Marco Perinelli; Massimo Messina; Michele Alessiani; Roberta Siniscalchi
 
Aug 18, 2026
 
Prev Next